OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
HKXCY Hong Kong Exchanges and Clearing Ltd
TOMZ TOMI Environmental Solutions Inc
GDXD MicroSectors? Gold Miners -3X Inverse Leveraged ETNs
CWK Cushman & Wakefield PLC
NAUT Nautilus Biotechnology Inc
ZSANQ Zosano Pharma Corp
CHX ChampionX Corp
UTZ UTZ Brands Inc
POSAF POSaBIT Systems Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

OraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's segments consist of Diagnostics and Molecular Solutions. Diagnostics business segment primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products. The Diagnostics business includes tests for diseases including COVID-19, human immunodeficiency virus (HIV) and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Molecular Solutions business products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Closing Price
$4.36
Day's Change
0.14 (3.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.81
Day's Low
4.11
Volume
(Heavy Day)
Volume:
1,972,193

10-day average volume:
1,483,414
1,972,193

Display:

Providers:

UpdateCancel
6 providers
August 09, 2022
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

InteliSwab revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production InteliSwab gross margins improve sequentially by over 2,000 basis points GAAP gross margin of 34.4%, a decrease of 200 basis points sequentially...(Globe Newswire)

August 02, 2022
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and certain business developments for 5:00 p.m. ET (2:00...(Globe Newswire)

July 28, 2022
OraSure's Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today its ongoing commitment to fight the...(Globe Newswire)

July 14, 2022
OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its OMNIgene?GUT DNA and RNA product...(Globe Newswire)

June 08, 2022
OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that on June 4, 2022, OraSure's Board of...(Globe Newswire)

May 25, 2022
InteliSwab(R) COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab COVID-19 Rapid Test...(Globe Newswire)

May 23, 2022
Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, today announced that Carrie Eglinton Manner has been...(Globe Newswire)

May 17, 2022
InteliSwab(R) COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab COVID-19 rapid tests...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.